Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2023-04-04 00:00:00 ET · period of report 2023-03-31 · accession 0001209191-23-022806 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-04 | 2023-03-31 | YARW | Zeronda Tyler | CFO | F - Tax | $3.08 | -384 | 8,108 | -5% | -$1,183 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | F | D | 384 | $3.08 | 8,108 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. (F2) On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split. |